Related Experiment Video
Updated: Aug 2, 2026

Studying Interactions of Staphylococcus aureus with Neutrophils by Flow Cytometry and Time Lapse Microscopy
Published on: July 17, 2013
PAF-releasing factor in human serum and inflammatory exudate
1Department of Biochemistry, School of Pharmaceutical Science, University of Shizuoka, Japan.
Abstract:
A factor responsible for releasing PAF produced in stimulated human polymorphonuclear leukocytes, which had been previously reported in human serum (Miwa et al. (1992) J. Immunol. 148, 872-880), was also confirmed to be present in inflammatory exudate. PAF-releasing factor, partially purified from human serum, was shown to possess higher affinity for PAF than for triacylglycerol, cholesterol ester, fatty acid or phosphatidylcholine. PAF bound to this factor aggregated washed rabbit platelets to the same extent as that bound to BSA, but was difficult to be hydrolyzed using PAF acetylhydrolase. These observations strongly suggest that PAF-releasing factor functions as a PAF carrier in blood and in the inflammatory response.
Insights
A novel PAF-releasing factor found in inflammatory exudate acts as a carrier for platelet-activating factor (PAF) in blood and during inflammation.
Area of Science:
- Immunology
- Biochemistry
Background:
- Platelet-activating factor (PAF) plays a crucial role in inflammatory responses.
- A PAF-releasing factor was previously identified in human serum.
Purpose of the Study:
- To confirm the presence of PAF-releasing factor in inflammatory exudate.
- To characterize the properties and function of this PAF-releasing factor.
Main Methods:
- Detection and partial purification of PAF-releasing factor from human serum and inflammatory exudate.
- Assays to determine the binding affinity of the factor for PAF and other lipids.
- Platelet aggregation studies using PAF bound to the factor.
- Hydrolysis resistance assays using PAF acetylhydrolase.
Main Results:
- PAF-releasing factor was confirmed in inflammatory exudate.
- The factor exhibited higher affinity for PAF compared to triacylglycerol, cholesterol ester, fatty acid, or phosphatidylcholine.
- PAF bound to the factor induced platelet aggregation similarly to BSA-bound PAF.
- The PAF-factor complex was resistant to hydrolysis by PAF acetylhydrolase.
Conclusions:
- The PAF-releasing factor identified in human serum is also present in inflammatory exudate.
- This factor functions as a carrier for PAF in both blood circulation and inflammatory processes.
- Its resistance to hydrolysis suggests a role in stabilizing PAF during inflammation.
Related Concept Videos
Inflammation
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the exudate's...
Acute Inflammation I: Inflammatory Response
Acute Inflammation II: Cellular Phase
Acute Inflammation III: Local and Systemic Effects

